FRST Primis Financial Corp. Insider Trading

F L Iii Garrett (Director) bought 1,300 shares at blended $14.57 over 5 days; stock up 16.0% in 90 days; 2 other insiders also bought recently.

F L Iii Garrett, a Director at Primis Financial Corp., executed 5 separate purchases totaling 1,300 shares for $18,935.63 between June 1–5, 2026, at prices ranging from $14.30 to $15.00. His holdings increased 2.8% to 47,934 shares post-transaction. The stock has appreciated 16.0% over the past 90 days and currently trades at $15.04, within 0.9% of its 52-week high of $15.18. Notably, his 5 prior purchases at FRST were all well-timed at the 90-day mark, with average 90-day returns of 4.2% per prior trade. A cluster pattern is present: 2 other insiders also bought within the past 14 days, suggesting synchronized buying interest at this price level.

Director Scott R Gamble bought 1,711 shares of Primis Financial (FRST) at $14.59; 2 other insiders bought within 14 days

Scott R Gamble, a director of Primis Financial, purchased 1,711 shares at $14.59 on 2026-06-03, increasing his holdings from 1,389 shares to 3,100 shares—a 123.2% increase in his position. This transaction occurred as part of a cluster buy pattern, with 2 other insiders also purchasing shares within the past 14 days. The company trades at a P/E of 7.95 with net income of $7,312,000.00, and the stock is currently at $14.79, down 2.0% from its 52-week high of $15.10. The convergence of multiple insider purchases within a tight timeframe, combined with the stock's proximity to 52-week highs and modest valuation multiple, may merit investor attention regarding board-level conviction.

Director Scott R Gamble bought 1,389 shares of FRST at $14.39; cluster of 2 other insiders also bought within 14 days

Director Scott R Gamble purchased 1,389 shares at $14.39, initiating a new position with a total value of $19,983.54. This transaction occurred as part of a cluster pattern, with 2 other insiders also buying within the past 14 days, suggesting coordinated or coincident interest at the current valuation. The stock is trading at $14.89, near its 52-week high of $14.97, and has risen 10.9% over the past 90 days, indicating positive momentum. At a P/E of 8.01 with a market cap of $368,856,152.08, the company shows modest valuation metrics relative to its net income of $7,312,000.00.

Director F L Iii Garrett bought 1,394 shares at FRST over 5 days (avg $14.46); 0 of 3 prior same-ticker buys were well-timed at 90 days.

F L Iii Garrett executed 5 separate purchases totaling 1,394 shares for $20,156.51 between May 22–29, 2026, increasing his holdings by 3.1% to 46,634 shares. The blended average price was $14.46, slightly above the current price of $14.36 and near the 52-week high of $14.97. Examining his prior trades at Primis, Garrett's three prior same-ticker buys show inconsistent timing: the 2025 purchases posted modest 30-day gains (+0.9% and +2.1%) but turned negative by 90 days (-2.8% and -2.6%), while the December 2024 buy was deeply underwater at both horizons (-14.1% at 30 days, -20.2% at 90 days). Across all tickers and all open-market history, his track record shows 0 of 3 prior buys were well-timed at the 90-day mark, with an average 90-day return of -8.5%. The current purchase near the 52-week high and just -2.3% from the 30-day mark, combined with this historical pattern of post-purchase declines, offers limited reassurance on timing accuracy.

Director Robert Yates Clagett buys 1,421 shares of FRST at $14.00; prior FRST buys showed mixed timing with 2 of 4 well-timed at 90-day mark.

Director Robert Yates Clagett purchased 1,421 shares at $14.00, bringing his total holdings to 53,665 shares. His prior four trades at FRST show a bifurcated pattern: two November 2025 purchases generated strong 90-day returns (+27.9% and +30.0%), while two December 2024 purchases resulted in 90-day losses (-20.9% and -20.4%), meaning 2 of 4 prior buys at this ticker were well-timed. The current share price of $14.15 sits -5.5% from the 52-week high of $14.97, and the company trades at a P/E of 7.61 with net income of $7,312,000.00. This purchase arrives after Clagett's recent successful accumulation pattern at FRST, though his cross-ticker track record shows more modest results (4 prior buys, 50.00% 90d win rate, +4.2% avg 90d return).

Director Clagett Robert Yates buys 1,410 shares of FRST at $14.16; adds to 50.8K-share position amid recent well-timed buys.

Clagett Robert Yates (Director) purchased 1,410 shares at $14.16 on 2026-05-14, expanding his holdings from 50,834 to 52,244 shares. This marks his fifth open-market purchase and follows a notable pattern at FRST: his two most recent buys at this ticker on 2025-11-13 and 2025-11-11 both showed strong 90-day performance (+27.9% and +30.0% respectively), suggesting favorable entry timing in late 2025. The current price of $14.00 is 6.5% below the 52-week high and essentially flat over 30 days, offering context for a continued accumulation posture. His cross-ticker track record shows 50% 90-day win rate, while same-ticker outcomes at FRST reveal 2 of 4 prior trades were well-timed at the 90-day mark—a pattern worth tracking if this transaction follows a similar trajectory.

Director Biagas buys 1,925 shares of FRST at $12.80; prior 5 trades at this ticker all underwater at 90 days (0 of 4 well-timed).

Director John Fitzgerald Biagas purchased 1,925 shares at $12.80 on 2026-03-12, raising his holdings to 91,944 shares. His prior same-ticker history at FRST shows a concerning pattern: all 4 prior measurable buys resulted in negative 90-day returns, ranging from -0.8% to -18.5%, and 0 of 4 were well-timed at the 90-day mark. The current stock price of $12.78 is 10.7% below the 52-week high of $14.31 and down 9.0% over the past 30 days. Additionally, company fundamentals are weak—the company reported negative net income over its most recent full fiscal year despite a current P/E of 36.51, suggesting the market is pricing in optimistic future earnings. The persistent pattern of poor timing outcomes across his FRST purchases, combined with deteriorating price action and negative full-year profitability, suggests caution rather than confidence.

Director Biagas buys 1,550 shares of FRST at $12.75; stock now -8.9% in 30d and -10.2% from 52w high.

Biagas John Fitzgerald, a Director, purchased 1,550 shares of Primis Financial Corp. at $12.75 on 2026-03-11, increasing his holdings to 90,019 shares. The purchase came at a point where the stock was trading -8.9% below its 30-day average and -10.2% from its 52-week high of $14.31. Examining his ticker-specific history at FRST, 0 of 4 prior buy transactions at this company were well-timed, with those prior buys showing 90-day returns of -0.8%, -17.9%, -18.5%, and -15.2% respectively. His cross-ticker track record across all open-market transactions shows 6 prior buys with an average 90-day return of -14.3% and a 0.00% win rate. Notably, the company reported a negative net income over its most recent full fiscal year, though current-period net income was $6,830,000.00, creating ambiguity about profitability trajectory.

Director Diaz bought 1,050 shares of FRST at $12.77; stock now $12.85, -10.2% from 52-week high.

Director Deborah Diaz purchased 1,050 shares at $12.77 on 2026-03-06, increasing her holdings to 21,122 shares (+5.2%). Her cross-ticker track record shows 4 prior buys with an average 90-day return of -2.7% and a 50% win rate, indicating modest historical accuracy. At FRST specifically, she has a mixed record: one prior buy (2025-12-10) delivered +5.0% over 90 days, but two earlier buys (2024-12-12 and 2024-03-15) saw declines of -20.0% and -17.7% respectively, with only 1 of 3 prior trades well-timed at the 90-day mark. The current stock price of $12.85 is -10.2% from its 52-week high of $14.31, having declined -8.9% over the past 30 days, reflecting recent weakness. Additionally, the company reported full-year net income was negative despite showing $6.8M in the current period, and carries a high P/E of 36.71, signaling elevated valuation relative to earnings.

Director William Rand Cook buys 1,770 shares of FRST at $14.17; prior buys at ticker show 0 of 4 well-timed at 90-day mark

Director William Rand Cook purchased 1,770 shares of Primis Financial at $14.17 on 2026-02-10, bringing his holdings to 46,202 shares. At the same ticker, his prior four completed trades (ranging from 2024-03-13 to 2025-02-06) all posted negative 90-day returns, from -15.0% to -21.9%, with zero of four achieving positive returns over the 90-day window. The company reported negative full-year net income in its most recent fiscal year, and the current P/E of 40.11 reflects a highly elevated valuation multiple. The stock has rebounded 5.6% over 30 days and 27.4% over 90 days from its lows, but the insider's historical pattern at this ticker offers no evidence of successful timing on prior accumulation attempts.